Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Article in English | IMSEAR | ID: sea-89138

ABSTRACT

Islets of Langerhans were isolated from the monkey pancreatic by collagenase digestion method. Freshly isolated monkey pancreatic islets were transplanted under the renal capsule of normal rats. Treated group of rats received Cyclosporine A injections and the control group of rats did not receive any drug. In Cyclosporine A treated rats the monkey islets were not destroyed. They maintained their normal structural integrity with occasional neutrophils surrounding the islets. In the untreated rats dense infiltration of neutrophils destroyed the islets in three days. On the seventh day dense infiltration of lymphocytes was seen. Granulomas composed of epitheloid cells and occasional multinucleated Langerhans type giant cells were seen on the fourteenth day.


Subject(s)
Animals , Cyclosporine/pharmacology , Female , Graft Rejection/pathology , Islets of Langerhans Transplantation/pathology , Macaca radiata , Male , Rats , Subrenal Capsule Assay , Transplantation, Heterologous/pathology , Transplantation, Heterotopic
2.
Acta cir. bras ; 12(1): 16-22, jan.-mar. 1997. ilus, tab, graf
Article in English | LILACS | ID: lil-197661

ABSTRACT

We studied the effects of islet of Langerhans transplantation (IT) on the kidney lesions of rats with alloxan-induced diabetes. Forty-five inbred male Lewis rats were randomly assigned to 3 experimental groups: group GI incliuded 15 non-diabetic control rats. (NC), group GII included 15 alloxan-induced diabetic rats (DC), and group III included 15 alloxan-induced diabetic rats that received pancreatic islet transplantation prepared by nonenzymatic method from normal donor Lewis rats and injected into the portal vein (IT). Each group was further divided into 3 subgroups of 5 rats which were sacrificed at 1, 3 and 6 months of follow-up, respectively. Clinical and laboratorialparameters were recorded in the mentioned periods in the 3 experimental groups. For histology, the kidneys of all rats of each subgroup were wtudied and 50 glomeruli and 50 tubules of each kidney were analyzed using light microscopy by two different investigators in a double blind study. The results showed progressive glomerular basement membrane thickening (GBMT), mesangial enlargement (ME),and Bowman's capsulethickening (BCT) in the 3 experimental groups throughout the follow-up...


Subject(s)
Animals , Male , Rats , Islets of Langerhans Transplantation/pathology , Diabetic Nephropathies/pathology , Alloxan , Diabetes Mellitus, Experimental , Follow-Up Studies , Islets of Langerhans Transplantation/adverse effects , Rats, Inbred Lew
3.
Braz. j. med. biol. res ; 25(12): 1185-95, 1992. tab, graf
Article in English | LILACS | ID: lil-134497

ABSTRACT

1. Forty-five outbred Wistar rats were randomly assigned to three experimental groups: GI, 10 non-diabetic control rats; GII, 10 alloxan-diabetic control rats; GIII, 25 alloxan-diabetic rats which received pancreaticoduodenal transplantation (PDT) from normal Wistar donor rats and were immunosuppressed with cyclosporin A (Cy-A), 10 mg kg body weight-1 day-1, administered intraperitoneally for 30 days. 2. In parallel, 15 alloxan-diabetic inbred Wistar rats received isogeneic PDT from normal Wistar donor rats. 3. Cy-A prevented graft rejection in the 15 surviving animals in group III. These observations were confirmed by clinical and biochemical parameters (body weight, urine output, water and food intake, blood and urinary glucose and plasma insulin) and by histology and immunohistochemistry of the pancreas. 4. However, Cy-A was associated with 60% of the infectious complications in transplanted rats leading to 40% mortality. Pulmonary infections were the main cause of death. There were no side effects of immunosuppression on the pancreas. Infections were not significant in inbred rats submitted to PDT


Subject(s)
Animals , Male , Female , Cyclosporine/therapeutic use , Diabetes Mellitus, Experimental/surgery , Duodenum/transplantation , Immunosuppression Therapy/methods , Islets of Langerhans Transplantation/immunology , Drug Evaluation , Diabetes Mellitus, Experimental/immunology , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Duodenum/immunology , Duodenum/pathology , Immunohistochemistry , Islets of Langerhans Transplantation/pathology , Pancreas/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL